Whitehawk Therapeutics, Inc.

WHWK
$4.02 (- $0.17 - 4.06%)
Last updated: 2026-07-07 00:32 UTC
WHWK Metrics
Exchange
🇺🇸 NASDAQ XNCM
Nasdaq Capital MarketUnited StatesAmerica/New_York
SectorHealthcare
IndustryBiotechnology
ISINUS00032Q1040
CUSIP00032Q104
Market Price4.02
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPS-0.64
Market Cap$125.8M
Book Value3.33
Price to Book0.801
Beta0.69
52w High3.81
52w Low1.39
Next Earnings DateN/A

Whitehawk Therapeutics, Inc. trades under ticker WHWK on NASDAQ as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US00032Q1040, CUSIP 00032Q104.

About the Company
Whitehawk Therapeutics, Inc., an oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides a three-asset antibody-drug conjugate (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in March 2025. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.
Price History